Power Life Sciences
San Francisco, California, 94107, United States
NCT Number: NCT05978258
Historically, participation in clinical studies is highly skewed towards particular demographic groups of people.
This research will invite several participants to gather a wide range of information on clinical trial experiences for cluster headache patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of cluster headache.
The data collected from this study will help improve future outcomes for all cluster headache patients as well as those in under-represented demographic groups.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
San Francisco, California, 94107, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months
Time frame: 12 months
Contact information is provided by the study sponsor or research team.
Power Life Sciences Inc.
Industry
An Observational Study Assessing the Experience of Patients Undergoing Active Cluster Headache Clinical Trials
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07714369
Brain Diseases, Central Nervous System Diseases
Houston, Texas, United States
View Trial DetailsNCT06882278
Agnosia, Brain Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT04930887
Brain Diseases, Central Nervous System Diseases
Stanford, California, United States
View Trial DetailsNCT06011811
Brain Diseases, Central Nervous System Diseases
Houston, Texas, United States
View Trial Details